Kalkine Media ASX Share Market News & Research
Sign Up/Login
https://kalkinemedia.com/resources/assets/public/img/flags/au.png AUS
https://kalkinemedia.com/resources/assets/public/img/flags/nz.png NZ
https://kalkinemedia.com/resources/assets/public/img/flags/uk.png UK
https://kalkinemedia.com/resources/assets/public/img/flags/ca.png CA
https://kalkinemedia.com/resources/assets/public/img/flags/us.png USA
https://kalkinemedia.com/resources/assets/public/img/flags/fr.png FRA
https://kalkinemedia.com/resources/assets/public/img/flags/de.png GER
https://kalkinemedia.com/resources/assets/public/img/flags/es.png ESP
https://kalkinemedia.com/resources/assets/public/img/flags/it.png ITA
https://kalkinemedia.com/resources/assets/public/img/flags/nl.png NLD
https://kalkinemedia.com/resources/assets/public/img/flags/pt.png PRT
https://kalkinemedia.com/resources/assets/public/img/flags/se.png SWE
https://kalkinemedia.com/resources/assets/public/img/flags/gr.png GRC
https://kalkinemedia.com/resources/assets/public/img/flags/in.png IND
https://kalkinemedia.com/resources/assets/public/img/flags/pl.png POL
https://kalkinemedia.com/resources/assets/public/img/flags/br.png BRA
https://kalkinemedia.com/resources/assets/public/img/flags/za.png ZAF
https://kalkinemedia.com/resources/assets/public/img/flags/ru.png RUS
https://kalkinemedia.com/resources/assets/public/img/flags/cn.png CHN
https://kalkinemedia.com/resources/assets/public/img/flags/ae.png UAE
Kalkine Media ASX Share Market News & Research

KOLON Biotech Participates in BIO Asia-Taiwan 2024 from July 25

July 22, 2024 02:00 AM CEST | By Cision
KOLON Biotech Participates in BIO Asia-Taiwan 2024 from July 25
Image source: Kalkine Media

Recent News

thumbnail

Milan Fashion Campus Launches Comprehensive Online Fashion Academy - B...

thumbnail

EarthSoft presenta soluzioni pratiche per la gestione dei contaminanti...

thumbnail

Profitto senza tariffe: HK Refurbished Stock offre iPhone rigenerati a...

thumbnail

Key Driver Transforming The Cloud Industry Market 2025: Rising Demand...

- Run an exhibit booth at the bio exhibition which will be held in Taipei, Taiwan for four days starting from July 25

- Exploring partnership with local and global companies considering entry into the US and Japanese markets

TAIPEI, July 22, 2024 /PRNewswire/ -- KOLON Biotech(CEO Sun-jin Kim), a subsidiary of KOLON Life Science Inc., announced on July 22 that it is running its own exhibit booth at BIO Asia-Taiwan 2024, which will be held in Taipei, Taiwan for four days from July 25.

KOLON Biotech Participates in BIO Asia-Taiwan 2024 from July 25
KOLON Biotech Participates in BIO Asia-Taiwan 2024 from July 25

BIO Asia-Taiwan 2024 is the largest bio exhibition in the country, co-organized by Biotechnology Innovation Organization (BIO) of the United States and Taiwan BIO. This year, it provides about 800 participating companies to regionally and globally link the production and value chains within the industry.

KOLON Biotech plans to strengthen its global networking by opening a solo booth at Hall 1 of Taipei Nangang Exhibition Center and exploring various business collaborations with global biotech companies including Taiwanese companies. In particular, it aims to secure mid to long-term partnerships with Taiwanese biotech companies which are developing excellent pipelines targeting the US and Japanese markets. It is expected that KOLON Biotech's cooperation model of providing samples at affordable cost and utilizing its excellent Chemistry, Manufacturing and Controls (CMC[1]).

KOLON Biotech will make an introduction to its Contract Development and Manufacturing Organization (CDMO[2]) service. This model allows the companies preparing for early-stage clinical trials to provide scalable process setup services leveraging accumulated commercialization experience. For those preparing for late-stage clinical trials, KOLON Biotech can deliver high-quality and high-yield products at reasonable price by applying its 2D Automated Closed Platform technology.

"Taiwan is one of the leading biomedical industry hubs in Asia and we plan to introduce our excellent process development services and capabilities to Asian companies considering the entry into the US or Japanese markets," said Sun-jin Kim, CEO at KOLON Biotech.

KOLON Biotech has been operating CDMO and Contract Manufacturing Organization (CMO[3]) specialized in advanced biopharmaceuticals, such as cell therapy, gene therapy and exosome therapy, based on its more than 20 years of experience. It has produced more than 100 commercial batches successfully in Korea alone and is gearing up itself for a number of projects for the commercial supply to Japan and the US.

[1] Chemistry, Manufacturing, and Controls

[2] Contract Development and Manufacturing Organization

[3] Contract Manufacturing Organization

 

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalized advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

Top Penny Picks under 20 Cents to Fit Your Pocket! Get Exclusive Report on Penny Stocks For FREE Now.

Sponsored Articles